US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 13.630
  • -0.640-4.48%
Close Oct 31 16:00 ET
  • 13.630
  • 0.0000.00%
Post 20:01 ET
239.82MMarket Cap-17701P/E (TTM)

Rigel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rigel Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 7, 2024

Estimate YoY
Revenue
41.93M
+49.05%
EPS
0.07
+123.34%
Analyst Rating
Buy

Oct 31, 2024

Rigel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 47.693M--
Nov 7, 20242024/Q3-- / 41.934M--
Aug 6, 20242024/Q236.841M / 33.704M--
May 7, 20242024/Q129.534M / 31.472M--
Mar 5, 20242023/Q435.792M / 33.415M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 47.693M--
Nov 7, 20242024/Q3-- / 41.934M--
Aug 6, 20242024/Q236.841M / 33.704M--
May 7, 20242024/Q129.534M / 31.472M--
Mar 5, 20242023/Q435.792M / 33.415M--

Unlock Free Earnings Estimates

Rigel Pharmaceuticals Earnings Reports

  • Rigel Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:09 ET

  • Rigel Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 16:58 ET

  • Rigel Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 5 16:09 ET

  • Rigel Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data